Chen Tangting, Chen Ni, Pang Ningbo, Xiao Lamei, Li Yongjie, Li Rong, Luo Mao, Deng Xin, Ren Meiping, Wu Jianbo, Wang Liqun
Key Laboratory of the Ministry of Education for Medical Electrophysiology and the Institute of Cardiovascular Research, Southwest Medical University, Luzhou, PR China.
J Vasc Res. 2016;53(5-6):245-254. doi: 10.1159/000452408. Epub 2016 Nov 29.
BACKGROUND: The flowers of Carthamus tinctorius L. are widely used in traditional Chinese medicine to treat cerebrovascular and cardiovascular diseases. Hydroxysafflor yellow A (HSYA), the main constituent of C. tinctorius L. flowers, is known for its multiple biological activities. The present study investigated the effects of HSYA on angiogenesis in vitro and in a mouse hindlimb ischemia model. METHODS: Using human umbilical vein endothelial cells (HUVEC) in vitro and a mouse hindlimb ischemia model in vivo, the angiogenic role of HSYA was evaluated. RESULTS: HSYA significantly increased the capillary-like tube formation and migration of HUVEC. HSYA not only induced a rise in the expression of angiopoietin 1 and Tie-2 but it also increased phosphorylation of Tie-2, Akt, and extracellular signal-regulated kinase 1/2. Furthermore, an anti-Tie-2 neutralizing antibody significantly inhibited HSYA-induced HUVEC tube formation and migration. In vivo, the recovery of perfusion of ischemic hindlimb tissue after femoral artery interruption was significantly increased in HSYA-treated mice compared to vehicle controls. Consistent with these results, the arteriole and capillary densities in ischemic gastrocnemius muscles were significantly increased in HSYA-treated mice. CONCLUSIONS: These results indicate the potential utility of HSYA for the treatment of ischemic diseases.
背景:红花在传统中药中广泛用于治疗脑血管和心血管疾病。羟基红花黄色素A(HSYA)是红花的主要成分,以其多种生物活性而闻名。本研究调查了HSYA在体外和小鼠后肢缺血模型中对血管生成的影响。 方法:利用体外人脐静脉内皮细胞(HUVEC)和体内小鼠后肢缺血模型,评估HSYA的血管生成作用。 结果:HSYA显著增加了HUVEC的毛细血管样管形成和迁移。HSYA不仅诱导血管生成素1和Tie-2的表达升高,还增加了Tie-2、Akt和细胞外信号调节激酶1/2的磷酸化。此外,抗Tie-2中和抗体显著抑制HSYA诱导的HUVEC管形成和迁移。在体内,与载体对照组相比,HSYA治疗的小鼠在股动脉中断后缺血后肢组织的灌注恢复显著增加。与这些结果一致,HSYA治疗的小鼠缺血腓肠肌中的小动脉和毛细血管密度显著增加。 结论:这些结果表明HSYA在治疗缺血性疾病方面具有潜在的应用价值。
Arterioscler Thromb Vasc Biol. 2010-1-7
Front Pharmacol. 2025-5-23
Evid Based Complement Alternat Med. 2022-5-12
Evid Based Complement Alternat Med. 2021-12-2
Front Pharmacol. 2021-9-2